Table 1 Clinical manifestations and characteristics of patients included in the study
FM (n = 51) | Group of FM | P value | ||
|---|---|---|---|---|
SPAP < 50 mmHg group; n = 26 | SPAP ≥ 50 mmHg groupn = 25 | |||
General information | ||||
Age at time of diagnosis, yrs | 64.04 ± 11.46 | 66.42 ± 9.99 | 61.56 ± 12.52 | 0.131 |
Male, % | 15(29.4%) | 8(30.8%) | 7(28.0%) | 0.828 |
History of smoking | 12(23.5%) | 8(30.8%) | 4(16.0%) | 0.214 |
Tuberculosis | ||||
Confirmed | 27(52.9%) | |||
Suspected | 7(13.7%) | |||
Clinical presentation | ||||
Dyspnea | 48(94.1%) | 23(88.5%) | 25(100.0%) | 0.235 |
Cough | 40(78.4%) | 20(76.9%) | 20(80.0%) | 0.789 |
Expectoration | 36(70.6%) | 17(65.4%) | 19(76.0%) | 0.406 |
Hemoptysis | 9(17.6%) | 6(23.1%) | 3(12.0%) | 0.465 |
Chest pain | 6(11.8%) | 4(15.4%) | 2(8.0%) | 0.668 |
Chest tightness | 25(49.0%) | 10(38.5%) | 15(60.0%) | 0.124 |
Palpitation | 1(2.0%) | 0(0.0%) | 1(4.0%) | 0.490 |
Fever | 9(17.6%) | 5(19.2%) | 4(16.0%) | 0.762 |
Peripheral edema | 19(37.3%) | 10(38.5%) | 9(36.0%) | 0.856 |
SVCS | 0(0.0%) | 0(0.0%) | 0(0.0%) | – |
Hoarseness | 0(0.0%) | 0(0.0%) | 0(0.0%) | – |
CRP | 12(23.5%) | 7(26.9%) | 5(20.0%) | 0.560 |
ESR | 9(17.6%) | 7(26.9%) | 2(8.0%) | 0.140 |